Multidisciplinary consensus on cancer management during pregnancy

被引:0
作者
A. Cubillo
S. Morales
E. Goñi
F. Matute
J. L. Muñoz
D. Pérez-Díaz
J. de Santiago
Á. Rodríguez-Lescure
机构
[1] Centro Integral Oncológico Clara Campal,Department of Medical Oncology
[2] Hospital Universitario HM Sanchinarro,Gynecologic Oncology Unit
[3] Sociedad Española de Oncología Médica (SEOM),Nuclear Medicine Service
[4] Hospital Universitario Infanta Leonor,Radiology Department
[5] Sociedad Española de Ginecología y Obstetricia (SEGO),Oncological Radiotherapy Service
[6] Complejo Hospitalario de Navarra,Gynecologic Oncology Unit
[7] Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM),Department of Medical Oncology
[8] Hospital Clínico San Carlos,undefined
[9] Sociedad Española de Radiología Médica (SERAM),undefined
[10] Hospital Universitario de Badajoz,undefined
[11] Sociedad Española de Oncología Radioterápica (SEOR),undefined
[12] General Surgery Service,undefined
[13] Hospital Clínico San Carlos,undefined
[14] Asociación Española de Cirujanos (AEC),undefined
[15] MD Anderson Cancer Center,undefined
[16] Sociedad Española de Ginecología y Obstetricia (SEGO),undefined
[17] Hospital General Universitario de Elche,undefined
[18] Sociedad Española de Oncología Médica (SEOM),undefined
[19] Grupo Español de Investigación en Cáncer de mama (GEICAM),undefined
来源
Clinical and Translational Oncology | 2021年 / 23卷
关键词
Antineoplastic agents; Child development; Diagnosis; Follow-up; Prenatal care; Radiotherapy; Surgery; Systemic therapies;
D O I
暂无
中图分类号
学科分类号
摘要
Cancer during pregnancy is a challenge for multi- and interdisciplinary collaboration due to the diagnostic, prognostic and therapeutic implications, the need for an integrated harmonization of medical action for the pregnant patient and the embryo or foetus and the characteristics of each gestational period, which will determine the protocol to be proposed and its limitations. For this reason, a group of experts appointed by participating scientific societies, which includes the Spanish Society of Medical Oncology (Sociedad Española de Oncología Médica—SEOM), the Spanish Association of Surgeons (Asociación Española de Cirujanos—AEC), the Spanish Society of Gynaecology and Obstetrics (Sociedad Española de Ginecología y Obstetricia—SEGO), the Spanish Society of Nuclear Medicine and Molecular Imaging (Sociedad Española de Medicina Nuclear e Imagen Molecular—SEMNIM), the Spanish Society of Oncological Radiotherapy (Sociedad Española de Oncología Radioterápica—SEOR) and the Spanish Society of Medical Radiology (Sociedad Española de Radiología Médica—SERAM), have worked together to establish consensus recommendations that allow the harmonization of management and ultimately the optimization of the healthcare of pregnant patients with cancer. When cancer is detected in a pregnant woman, the week of gestation in which the diagnosis is made must be considered, as well as the characteristics of the tumour. It is strongly recommended that a multidisciplinary team assesses the situation and guides the patient and her family during the informing, diagnosis and treatment process. Likewise, the foetus should be monitored and managed by specialized obstetricians who are part of a multidisciplinary cancer committee.
引用
收藏
页码:1054 / 1066
页数:12
相关论文
共 492 条
  • [1] Eibye S(2013)Incidence of pregnancy-associated cancer in Denmark, 1977-2006 Obstet Gynecol 122 608-617
  • [2] Kjaer SK(2017)Frequency of pregnancy related cancer: a population based linkage study in Lombardy, Italy Int J Gynecol Cancer 27 613-619
  • [3] Mellemkjaer L(2002)Coexistence of pregnancy and malignancy Oncologist 7 279-287
  • [4] Parazzini F(2017)Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy Breast Cancer Res Treat 35 561-564
  • [5] Franchi M(2017)Sentinel lymph node biopsy for patients with early-stage breast cancer: american society of clinical oncology clinical practice guideline update J Clin Oncol 24 vi160-vi170
  • [6] Tavani A(2013)Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 47 1202-1208
  • [7] Negri E(2013)The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer Eur J Nucl Med Mol Imag 1 1145-1153
  • [8] Peccatori FA(2006)Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients J Nucl Med 31 65-69
  • [9] Pavlidis NA(2015)Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients JAMA Oncol 20 689-696
  • [10] Han SN(2017)Pregnancy and melanoma: a European-wide survey to assess current management and a critical literature overview J Eur Acad Dermatol Venereol 14 585-593